ELI LILLY & Co — Director's Dealing 2015

Feb 12, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2015-02-11

Reporting Person: Mahony Susan (SVP & Pres., Lilly Oncology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-02-11	Common Stock	M	9036	$56.18	Acquired	95793	Direct
2015-02-11	Common Stock	F	8065	$70.50	Disposed	87728	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-11	Employee stock option 2/06 (right to buy)	$56.18	M	9036	Disposed	2016-02-09	Common Stock (9036.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1599	Indirect
Common Stock	1589	Indirect
Common Stock	8984	Indirect

Footnotes

F1: Reporting person disclaims beneficial ownership of these shares.